Brookline analyst Tyler Bussian upgraded CervoMed (CRVO) to Buy from Hold with a $16 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRVO:
Brookline analyst Tyler Bussian upgraded CervoMed (CRVO) to Buy from Hold with a $16 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRVO: